Trends in and drivers of healthcare expenditure in the English NHS: a retrospective analysis

Abstract

Background: In England, rises in healthcare expenditure consistently outpace growth in both GDP and total public expenditure. To ensure the National Health Service (NHS) remains financially sustainable, relevant data on healthcare expenditure are needed to inform decisions about which services should be delivered, by whom and in which settings. Methods: We analyse routine data on NHS expenditure in England over 9 years (2008/09 to 2016/17). To quantify the relative contribution of the different care settings to overall healthcare expenditure, we analyse trends in 14 healthcare settings under three broad categories: Hospital Based Care (HBC), Diagnostics and Therapeutics (D&T) and Community Care (CC). We exclude primary care and community mental health services settings due to a lack of consistent data. We employ a set of indices to aggregate diverse outputs and to disentangle growth in healthcare expenditure that is driven by activity from that due to cost pressures. We identify potential drivers of the observed trends from published studies. Results: Over the 9-year study period, combined NHS expenditure on HBC, D&T and CC rose by 50.2%. Expenditure on HBC rose by 54.1%, corresponding to increases in both activity (29.2%) and cost (15.7%). Rises in expenditure in inpatient (38.5%), outpatient (57.2%), and A&E (59.5%) settings were driven predominately by higher activity. Emergency admissions rose for both short-stay (45.6%) and long-stay cases (26.2%). There was a switch away from inpatient elective care (which fell by 5.1%) and towards day case care (34.8% rise), likely reflecting financial incentives for same-day discharges. Growth in expenditure on D&T (155.2%) was driven by rises in the volume of high cost drugs (270.5%) and chemotherapy (110.2%). Community prescribing grew by 45.2%, with costs falling by 24.4%. Evidence on the relationship between new technologies and healthcare expenditure is mixed, but the fall in drug costs could reflect low generic prices, and the use of health technology assessment or commercial arrangements to inform pricing of new medicines. Conclusions: Aggregate trends in HCE mask enormous variation across healthcare settings. Understanding variation in activity and cost across settings is an important initial step towards ensuring the long-term sustainability of the NHS.

Formal health care costs among older people in Ireland: methods and estimates using The Irish Longitudinal Study on Ageing (TILDA)

“…The estimation that hospital costs account for nearly 60% of total costs is higher than comparable data in England (50%) 75 . This is potentially associated with Ireland’s historic reliance on acute care and weak primary care capacity, and implies opportunity to reduce hospital costs through more cost-effective models of community care delivery 16 , 21 .…”

Analysis of the Household and Health Care System Expenditures in Bulgaria

“…Expenditures for hospital care increased by 54.1%, corresponding to increases in both activity (29.2%) and cost (15.7%), whereas community prescription grew by 45.2%, with costs falling by 24.4% due to generic utilization and HTA implementation. Overall, it accounts for over one-fifth of the total expenditure in the English NHS (14).…”

The usage of data in NHS primary care commissioning: a realist review

“…It has been argued that evidence-based commissioning is particularly pertinent as the NHS is facing severe financial and demographic challenges, with costs in expenditure expected to rise in the medium-to longterm even according to conservative estimates [20,21]. Some health economists have argued that in order to remain financially sustainable, commissioners must utilise data on healthcare expenditure and understand drivers of variation of activity to help achieve significant cost savings [20,22].…”